Las Vegas, NV -- (SBWIRE) -- 10/01/2013 -- Value Stock Pick is a leading Investment Newsletter. Our Research Team conducts research on different stocks, doing their due diligence to provide a detailed report, including both technical and fundamental analysis, on NYSE, NASDAQ, AMEX, OTCBB and Pink Sheet Stocks. Let’s have a brief look at: Dynavax Technologies Corporation (NASDAQ:DVAX), Golden Star Resources Ltd. (USA) (NYSEMKT:GSS), Flow International Corporation (NASDAQ:FLOW), Omeros Corporation (NASDAQ:OMER).
Dynavax Technologies Corporation (NASDAQ:DVAX) managed to keep its fall at -6.30% on traded volume of 1.35 million shares. The stock settled at $1.19 after floating in a range of $1.18 to $1.28. After recent close, it has reached market capitalization of $217.76 million. Its 52-week range has been $0.98 to $5.10. Dynavax Technologies Corporation, a clinical-stage biopharmaceutical company, discovers and develops novel products to prevent and treat infectious and inflammatory diseases.
Will DVAX Get Buyers Even After The Recent Rally? Find Out Here
Golden Star Resources Ltd. (USA) (NYSEMKT:GSS) traded down on a volume of 2.36 million, lower than its standard daily volume. Shares have dropped -3.61% to $0.400. Over the last twelve months the stock has lost -79.7% and faced a worst price of $0.40. Golden Star Resources Ltd. engages in the acquisition, exploration, development, and operation of gold properties.
Will GSS Get Buyers Even After The Recent Rally? Find Out Here
Flow International Corporation (NASDAQ:FLOW) settled 0.25% higher at $3.99 on traded volume of 19.73 million shares during the last trading day, while its average trading volume remained 195.24 million shares. The stock has its 12-month low at $2.85 and 52-week high price was $4.09. It traded in a range of $3.97 to $4.00 during the last trading day. Flow International Corporation, a technology-based manufacturing company, provides water jet cutting and surface preparing solutions.
Will FLOW Continue To Move Higher? Find Out Here
Omeros Corporation (NASDAQ:OMER) saw its price fall on traded volume 1.70 million shares changed hands when compared with its average daily volume of 1.37 million shares. The stock was down -1.12% to $9.75. It has gained over the last 12 months, increasing 3.72% and marked new low $3.65. Omeros Corporation, a clinical-stage biopharmaceutical company, engages in discovering, developing, and commercializing products targeting inflammation, coagulopathies, and disorders of the central nervous system.
Will OMER Get Buyers Even After The Recent Rally? Find Out Here
PLEASE NOTE WELL: The employees of ValueStockPick.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site, Press releases or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Please Read Our Full Disclaimer at http://www.valuestockpick.com/disclaimer/
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)